Second edition

08.qxd 3/10/08 9:38 AM Page 388
388 Neurodegenerative and movement disorders
Hayflick SJ, Penzien JM, Michl W et al. Cranial MRI changes may
preceded symptoms in Hallervorden-Spatz syndrome. Pediatr
Neurol 2001; 25:166–9.
Hayflick SJ, Westaway SK, Levinson B et al. Genetic, clinical, and
radiographic delineation of Hallervorden-Spatz syndrome.
N Engl J Med 2003; 348:33–40.
Hely MA, Reid WGJ, Halliday GM et al. Diffuse Lewy body disease:
clinical features in nine cases without coexistent Alzheimer’s
disease. J Neurol Neurosurg Psychiatry 1996; 60:531–8.
Henderson JM, Carpenter K, Cartwright H et al. Loss of thalamic
and intralaminar nuclei in progressive supranuclear palsy and
Parkinson’s disease: clinical and therapeutic implications.
Brain 2000; 123:1410–21.
Heston LL, White JA, Mastri AR. Pick’s disease. Clinical genetics
and natural history. Arch Gen Psychiatry 1987; 44:409–11.
Heutink P, Stevens M, Rizzu P et al. Hereditary frontotemporal
dementia is linked to chromosome 17q21–q22: a genetic and
clinicopathological study of three Dutch families. Ann Neurol
1997; 41:150–9.
Higgins JJ, Adler RI, Loveless JM. Mutational analysis of the tau
gene in progressive supranuclear palsy. Neurology 1999;
53:1421–4.
Hillen ME, Sage JI. Nonmotor fluctuations in patients with
Parkinson’s disease. Neurology 1996; 47:1180–3.
Hipola D, Mateo D, Gimenez-Roldan S. Meige’s syndrome: acute
and chronic responses to clonazepam and anticholinergics. Eur
Neurol 1984; 23:474–8.
Hirano A, Arumugasamy N, Zimmerman HM. Amyotrophic lateral
sclerosis: a comparison of Guam and classical cases. Arch
Neurol 1967; 16:357–63.
Hirono N, Mori E, Yasuda M et al. Factors associated with
psychotic symptoms in Alzheimer’s disease. J Neurol Neurosurg
Psychiatry 1998; 64:648–52.
Hirose G, Bass NH. Metachromatic leukodystrophy in the adult: a
biochemical study. Neurology 1972; 22:312–20.
Hoehn MM, Yahr MD. Parkinsonism: onset, progression and
mortality. Neurology 1967; 17:427–42.
Holroyd S, Currie L, Wooten GF. Prospective study of
hallucinations and delusions in Parkinson’s disease. J Neurol
Neurosurg Psychiatry 2001; 70:734–8.
Hoogendijk WJG, Sommer IEC, Pool C et al. Lack of association
between depression and loss of neurons in the locus
coeruleus in Alzheimer disease. Arch Gen Psychiatry 1999;
56:45–51.
Hoogenraad TU, Van Hattum J, Van den Hamer CJA. Management
of Wilson’s disease with zinc sulphate: experience in a series
of 27 patients. J Neurol Sci 1987; 77:137–46.
Horimoto Y, Matsumoto M, Akatsu H et al. Autonomic
dysfunction in dementia with Lewy bodies. J Neurol 2003;
250:530–3.
Houser M, Waltz T. Meige syndrome and pallidal deep brain
stimulation. Mov Disord 2005; 20:1203–5.
Howard CP, Royce CE. Progressive lenticular degeneration
associated with cirrhosis of the liver (Wilson’s disease). Arch
Int Med 1919; 24:497–508.
Howeler CJ, Busch HF, Geraedts JP et al. Anticipation in myotonic
dystrophy: fact or fiction? Brain 1989; 112:779–97.
Hsieh M, Li S-Y, Tsai C-J et al. Identification of five
spinocerebellar ataxia type 2 pedigrees in patients with
autosomal dominant cerebellar ataxia in Taiwan. Acta Neurol
Scand 1999; 100:189–98.
Huber SJ, Kissel JT, Shuttleworth EC et al. Magnetic resonance
imaging and clinical correlates of intellectual impairment in
myotonic dystrophy. Arch Neurol 1989; 46:536–40.
Huff FJ, Boller J, Luchelli F et al. The neurologic examination in
patients with probable Alzheimer’s disease. Arch Neurol 1987;
44:929–32.
Hughes AJ, Daniel SE, Blankson S et al. A clinicopathologic study
of 100 cases of Parkinson’s disease. Arch Neurol 1993;
50:140–8.
Hung SW, Hamani C, Lozano AM et al. Long-term outcome of
bilateral pallidal deep brain stimulation for primary cervical
dystonia. Neurology 2007; 68:4579–9.
Huntington G. On chorea. Med Surg Reporter Philadelphia 1872;
26:317–21.
Huntington Study Group. Tetrabenazine as antichorea therapy in
Huntington disease: a randomized controlled trial. Neurology
2006; 66:366–72.
Hurtig HI, Trojanowski JQ, Galvin J et al. Alpha-synuclein cortical
Lewy bodies correlate with dementia in Parkinson’s disease.
Neurology 2000; 54:1916–21.
Hussain IF, Brady CM, Swinn MJ et al. Treatment of erectile
dysfunction with sildenafil citrate (Viagra) in parkinsonism due
to Parkinson’s disease or multiple system atrophy. J Neurol
Neurosurg Psychiatry 2001; 71:371–4.
Hutton JT, Koller WC, Ahlskog JE et al. Multicenter, placebocontrolled
trial of cabergoline taken once daily in the
treatment of Parkinson’s disease. Neurology 1996; 46:1062–5.
Hyde TM, Ziegler JC, Weinberger DR. Psychiatric disturbances in
metachromatic leukodystrophy: insights into the neurobiology
of psychosis. Arch Neurol 1992; 49:401–6.
Hyde TM, Stacey ME, Coppoa R et al. Cerebral morphometric
abnormalities in Tourette’s syndrome: a quantitative MRI
study of monozygotic twins. Neurology 1995; 45:1176–82.
Iizuka R, Hirayama K, Maehara KA. Dentato-rubro-pallido-luysian
atrophy: a clinico-pathological study. J Neurol Neurosurg
Psychiatry 1984; 47:1288–98.
Ikeda K, Akiyama H, Iritani S et al. Corticobasal degeneration with
primary progressive aphasia and accentuated cortical lesion in
superior temporal gyrus: case report and review. Acta
Neuropath 1996; 92:534–9.
Ikeda Y, Shizuka M, Watanabe M et al. Molecular and clinical
analysis of spinocerebellar ataxia type 8 in Japan. Neurology
2000; 54:950–5.
Ikeuchi T, Takano H, Koide R et al. Spinocerebellar ataxia type 6:
CAG repeat expansion in alpha1a voltage-dependent calcium
channel gene and clinical variations in Japanese population.
Ann Neurol 1997; 42:879–84.
Illarioshkin SN, Markova ED, Slominsky PA et al. The GTP
cyclohydrolase I gene in Russian families with doparesponsive
dystonia. Arch Neurol 1998; 55:789–92.
in t’ Veld BA, Ruitenberg A, Hofman A et al. Nonsteroidal
antiinflammatory drugs and the risk of Alzheimer’s disease.
N Engl J Med 2001; 345:1515–21.